Medical devices, healthcare technology and the business of care
510(k) clearance · K262495

Miru 1day UpSide (midafilcon A)

Menicon Co, Ltd. · Decision date Sep 17, 2026

MEDTECHLEDGER EXPLANATIONK262495

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-17 for K262495, submitted by Menicon Co, Ltd. of Nagoya, Japan, for the device Miru 1day UpSide (midafilcon A). The application is a traditional 510(k) received on 07/20/2026, reviewed by FDA rather than a third party, and not recorded as a combination product. A SESE decision is a clearance finding, not a premarket approval of the device.

The device falls under regulation number 886.5925 in the Ophthalmic medical specialty, with classification product code LPL and subsequent product code MVN; the FDA page lists the classification name as Lenses, Soft Contact, Daily Wear. The record does not state which predicate device was used, what testing supported equivalence, or any labeling, wear-schedule or indication details. The linked summary document was not part of the public information, so its contents remain unknown.

The correspondent of record is Andre Vision and Device Research of West Linn, Oregon, with Bret Andre listed as correspondent contact and Kana Nagasaki as applicant contact. No clinical, performance or postmarket data appear in the public information, and nothing in it supports conclusions about safety, efficacy or current labeling.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Ophthalmic
Decision date
Sep 17, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262495
Regulatory pathway
510(k) premarket notification
Product code
LPL
Decision code
SESE
Decision date
Sep 17, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Lenses, Soft Contact, Daily Wear.

Product code
LPL
FDA device class
2

FDA decision timeline

  1. K262495 received

    Application receipt date recorded by FDA.

  2. K262495 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LPL

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Menicon Co, Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Nagoya

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records